Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment
NCT ID: NCT03269786
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-11-01
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients
NCT05228509
Optimal Time for Follow up After Variceal Band Ligation
NCT04602663
Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease
NCT04998214
Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.
NCT03241823
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis
NCT05302661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cirrhotic patients with esophagel varisces
Endoscopic band ligation or injection scelerotheraby will be done for all patients
Liver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC)
Liver function tests will be assessed after endoscopic varisceal treatment for 6 monthes
biannual ultrasonography
portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.will be assessed after endoscopic varisceal treatment by using biannual ultrasonography for 6 monthes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC)
Liver function tests will be assessed after endoscopic varisceal treatment for 6 monthes
biannual ultrasonography
portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.will be assessed after endoscopic varisceal treatment by using biannual ultrasonography for 6 monthes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Abdelhamed
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
laucaevt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.